The excitement around Moderna's cancer vaccine is cooling. Here's why.
Moderna Inc MRNA
News
Moderna's cancer vaccine is 'likely' to get approved. Skeptics question if it will be the best option.
Lost Money on Moderna, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 23.07% Share Price Drop
Did You Lose Money on Moderna, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 23.07% Share Price Decline
The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?
Moderna Named a Top Employer by Science for Twelfth Consecutive Year
Moderna's cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
Lost Money on Moderna, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 23.07% Stock Decline
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
Moderna has a plan to revolutionize how certain cancers are treated. We're about to find out its potential in melanoma.
7 healthcare stocks that stand out as investors pay up for the sector
7 healthcare stocks that stand out as -2-
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
Flu season is already here. Here's what to know about this year's flu shots.
Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug
Citi tells investors it's time to sell Moderna after 600%-plus stock gains
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters.
Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
United States